BBI, volume has been so low, it doesn’t seem like anyone is unloading en masse.
Although it does feel like something has changed. The trading volume has fallen off a cliff since August. It’s like there’s no more shorting, but also no buying. Not sure if there is any significance to what has changed, or just that interest has dried up.
I agree that I hope there is some sort of announcement coming. It feels like we are in a state of purgatory right now.
Despite the keen interest by everyone on the legal front, I don’t really believe that will bear fruit anytime soon (if at all).
My hope still remains that something is coming with the new formulation.
I’m not sure an AG does anything meaningful, unless it would be done with the express purpose of rolling out the new formulation as the “brand”, and then placing the authorized generic next to it.
But I honestly don’t know enough about the dynamics of that business to know if this would even work to recapture the U.S. market from the generics.
But the new formulation could possibly allow them to begin marketing again, which is the only thing that will expand their footprint in the U.S.